AI assistant
TeamViewer AG — Investor Presentation 2020
Nov 10, 2020
430_ip_2020-11-10_2d1f1a1e-4764-43d5-8fd9-4d5da3f51ef3.pdf
Investor Presentation
Open in viewerOpens in your device viewer
Q3 2020 Investor Presentation
10 November 2020
Importance Notice
This presentation as well as any information communicated in connection therewith (the "Presentation") contains information regarding TeamViewer AG (the "Company") and its subsidiaries (the Company, together with its subsidiaries, "TeamViewer"). It is being provided for informational purposes only and should not be relied on for any purpose and may not be redistributed, reproduced, published, or passed on to any other person or used in whole or in part for any other purpose.
All stated figures are unaudited.
Certain statements in this presentation may constitute forward looking statements. These statements are based on assumptions that are believed to be reasonable at the time they are made, and are subject to significant risks and uncertainties, including, but not limited to, those risks and uncertainties described in TeamViewer's disclosures. You should not rely on these forward-looking statements as predictions of future events and we undertake no obligation to update or revise these statements. Our actual results may differ materially and adversely from any forward-looking statements discussed in these statements due to several factors, including without limitation, risks from macroeconomic developments, external fraud, lack of innovation capabilities, inadequate data security and changes in competition levels.
The Company undertakes no obligation, and does not expect to publicly update, or publicly revise, any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to it or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained elsewhere in this Presentation.
This document contains certain alternative performance measures (collectively, "APMs") including billings and Adjusted EBITDA that are not required by, or presented in accordance with, IFRS, German GAAP or any other generally accepted accounting principles. TeamViewer presents APMs because they are used by management in monitoring, evaluating and managing its business and management believes these measures provide an enhanced understanding of TeamViewer's underlying results and related trends. The definitions of the APMs may not be comparable to other similarly titled measures of other companies and have limitations as analytical tools and should, therefore, not be considered in isolation or as a substitute for analysis of TeamViewer's operating results as reported under IFRS or German GAAP. APMs such as billings and Adjusted EBITDA are not measurements of TeamViewer's performance or liquidity under IFRS or German GAAP and should not be considered as alternatives to results for the period or any other performance measures derived in accordance with IFRS, German GAAP or any other generally accepted accounting principles or as alternatives to cash flow from operating, investing or financing activities.
TeamViewer has defined each of the following APMs as follows:
"Billings" represent the (net) value of goods and services invoiced to customers in a given period if realization is probable – it is defined as revenue adjusted for change in deferred revenue P&L-effective; "Adjusted EBITDA" means EBITDA, adjusted for P&L-effective changes in deferred revenue as well as for certain special items relating to share based compensations and other material items that are not reflective of the operating performance of the business.
This document also includes further certain operational metrics, such as Net Retention Rate, and additional financial measures that are not required by, or presented in accordance with IFRS, German GAAP or any other generally accepted accounting principles (collectively, "other financial measures"). TeamViewer presents these operational metrics and other financial measures for information purposes and because they are used by the management for monitoring, evaluating and managing its business. The definitions of these operational metrics and other financial metrics may not be comparable to other similarly titled measures of other companies and have limitations as analytical tools and should, therefore, not be considered in isolation or as a substitute for analysis of TeamViewer's operating results, performance or liquidity as reported under IFRS or German GAAP.
TeamViewer has defined these operational metrics and other financial measures for information purposes as follows:
"Net retention rate" means annual recurring billings of existing subscription customers during the period considered less gross value churn plus billings from upselling and cross-selling, including foreign exchange effects and expiring discounts, as a percentage of annual recurring billings in the previous period;
"Levered free cash flow" (FCFE) means net cash from operating activities less capital expenditure for property, plant and equipment and intangible assets (excl. M&A), payments for the capital element of lease liabilities and interest paid for borrowings and lease liabilities; and
"Net Leverage" means the ratio of net financial debt (sum of interest-bearing loans and borrowings, current and non-current, less cash and cash equivalents) to Adjusted EBITDA.
Business Overview
Oliver Steil
Q3: Strong Performance And First Acquisition Since IPO
Financial Performance Further Highlights
| Q3 | 9M | |
|---|---|---|
| Billings | +29% yoy1 +34% cc2 |
+48% yoy +50% cc |
| Adj. EBITDA | +26% yoy +34% cc |
+58% yoy +61% cc |
| Adj. EBITDA Margin |
55% | 57% |
- Very good and balanced contribution from all growth initiatives
- Overachieved growth targets set at IPO
- Ubimax acquisition closed and integration progressing well with first success in Frontline/AR cross-selling
- Further application integrations with key partners
- Growing enterprise customer base with strong momentum in strategic solutions sales
1) Reported growth year-on-year
2) Growth at constant currencies
Growing Enterprise Subscriber Base With Rising Deal Sizes…
Top 50 Deals Accumulated Contract Value LTM (€m) Subscribers With Annual Contract Value Above €10k (LTM)1 2
1) Subscriber with invoiced billings of at least €10,000 p.a. across all purchased products and services during the last twelve months
2) The EUR aggregate value of the top 50 invoices during the last twelve months – not considering renewals
…Driven By Strong Momentum In Strategic Solutions Sales Selection of Q3 Transactions
| Sector | Country | ACV in € | License | Use Cases |
|---|---|---|---|---|
| Logistics | USA | >100k | Frontline | Vision picking with smart glasses for hands-free and paperless processes |
| Industrials | USA | >100k | Frontline | AR worker guidance for manufacturing, maintenance and logistics |
| Household Products | USA | >100k | Frontline | AR remote support for workflow guidance |
| Mining | USA | >100k | Tensor | Global IT tech support for various devices |
| Logistics | Mexico | >50k | Frontline | Vision picking with smart glasses for hands-free and paperless processes |
| Industrials | USA | >50k | Tensor | Internal tech support that features high security standards and ease of use |
| Construction | Spain | >50k | Tensor | Internal support of over 22.000 devices |
| IT Services | USA | >50k | Tensor | Supporting digital signage solutions |
| Publishing | USA | <50k | Tensor | Work from home for Design Departments with high performance requirements |
| Public Sector | USA | <50k | Tensor | IT support for 23,000 employees |
| IT Services | Denmark | <50k | Tensor | External IT service provider - over 150 agents managing a multitude of devices |
| Medical Technology | USA | <50k | Tensor/Pilot | Remote customer support & training |
Ubimax Integration Progressing Very Well
Business impact starting to materialize
Mastertitelformat bearbeiten Over-Delivered The IPO Growth Plan - Ready For More
2.5 billion Installed Devices3
+64% France Billings1
+54% RMM Billings1
Best in Class Financial Profile - Rule of 100: Billings up 44% with 58% Adj. EBITDA margin1
TAM of €40bn:
Taking advantage of unpenetrated growth markets in AR and IoT
1) LTM 30 Sep 2020 or yoy growth
2) Incl Ubimax
3) As of 6 November 2020
Financial Overview
Stefan Gaiser
Delivering Strong Growth and High Profitability…
1) Including Ubimax contributing €0.6m billings in Q3
2) Adj. EBITDA as % of Billings
…With Growing Subscriber Base And Continuously High NRR
- Continued growth of new subscribers
- Successful migration of long tail of perpetual customers proves product stickiness
Subscribers (thousand, LTM) Billings By Category (€m, LTM) Net Retention Rate
- Growing contribution from new license sales on top of strong Q3 2019
- Continued low churn
-
FX effects negatively impacting reported billings
-
104% (LTM, 30 September 2020)
- Consistently above 100% since the transition from perpetual to subscription licenses
- Unchanged up & cross sell and value churn; small decrease due to FX effects
Expanded Global Coverage Resulting in Well Balanced Growth
116.0
- Strong mid-market and Enterprise business
-
Weaker US\$ reduces reported growth
-
Very good contribution from Inside Sales and Resellers
-
Longer sales cycles for larger Enterprise deals
-
Significant growth acceleration in key countries across all sales channels
- Japan ahead of plan and strong contribution from China
+49%
9M 2019 9M 2020
172.9
Strong Business Model Drives Superior Margins…
Future growth supported by investments across all functions
| €m | Q3 20 | Q3 19 | ∆ | 9M 20 | 9M 19 | ∆ |
|---|---|---|---|---|---|---|
| Billings | 106.4 | 82.7 | +29% | 332.1 | 224.3 | +48% |
| Cost of Sales of % Billings |
(9.4) 8.8% |
(6.3) 7.6% |
+48% | (26.3) 7.9% |
(17.3) 7.7% |
+52% |
| Gross Profit Margin % |
97.1 +91.2% |
76.4 +92.4% |
+27% -1.2pp |
305.8 92.1% |
207.0 92.3% |
+48% -0.2pp |
| Sales of Billings % |
(14.0) 13.2% |
(9.9) 12.0% |
+41% | (41.5) 12.5% |
(28.4) 12.7% |
+46% |
| Marketing of Billings % |
(7.6) 7.1% |
(5.5) 6.6% |
+39% | (21.8) 6.6% |
(16.2) 7.2% |
+35% |
| R&D of % Billings |
(8.9) 8.3% |
(6.6) 8.0% |
+35% | (24.2) 7.3% |
(20.5) 9.2% |
+18% |
| G&A of Billings % |
(6.5) 6.1% |
(4.1) 4.9% |
+59% | (19.0) 5.7% |
(12.3) 5.5% |
+54% |
| Other1 of Billings % |
(2.0) 1.8% |
(4.3) 5.2% |
-55% | (10.1) 3.0% |
(10.0) 4.4% |
+1% |
| Total Opex of Billings % |
(38.9) 36.5% |
(30.4) 36.7% |
+28% | (116.5) 35.1% |
(87.5) 39.0% |
+33% |
| Adj. EBITDA | 58.2 | 46.0 | +26% | 189.3 1) incl. other income/expenses and bad debt expenses of €3.4m in Q2 and €8.5m for H1 2020 |
119.6 | +58% |
| Margin % |
7% 54 |
6% 55 |
-0 9pp |
0% 57 |
53 3% |
+3 7pp |
- Q3 Cost of Sales up as anticipated and reflecting investments in platform infrastructure fully in line with financial model
- Expansion of solutions sales and continued investments in R&D (+124 FTEs YTD), mainly in the areas of AR and IoT
- Lower bad debt expenses
- 9M Adj. EBITDA margin up 3.7pp
1) incl. other income/expenses and bad debt expenses of €2.2m in Q3 and €10.8 for 9M 2020 (€4.6m in Q3 2019 and €11.3m for 9M 2019)
…Translating Into High Operating And Levered Free Cash Flow
| €m | Q3 20 | Q3 19 | ∆ | 9M 20 | 9M 19 | ∆ |
|---|---|---|---|---|---|---|
| Pre-Tax Net Cash from Operating Activities (IFRS) |
57.4 | 36.0 | +60% | 185.1 | 98.9 | +87% |
| Income Tax Paid | (7.0) | (5.0) | +41% | (24.7) | (15.2) | +62% |
| Capital Expenditure (excl. M&A) | (7.7) | (0.2) | >100% | (22.8) | (8.1) | +180% |
| Lease Repayments | (1.6) | (1.5) | +9% | (3.4) | (3.8) | -13% |
| Interest Paid for Borrowings and Lease Liabilities |
(11.2) | (0.2) | >100% | (24.8) | (26.5) | -6% |
| Levered Free Cash Flow (FCFE) | 29.9 | 29.1 | +3% | 109.4 | 45.2 | +142% |
| as % of Adj. EBITDA | 51% | 63% | 58% | 38% | ||
| as % of EBITDA | 55% | 107% | 70% | 33% |
- 9M 2020 pre-tax net cash from operating activates up 87%
- One-off capital expenditure related to ERP system (€11.9m) and new headquarters (€6.2m) in 9M 2020 increasing capital expenditure to €22.8m YTD
- No loan interest paid in Q3 2019
- 9M 2020 levered free cash flow benefitting from lower loan interest
Ubimax Cash Consideration Funded With Operating Cash Flow Gross debt reduced and net leverage at 2.0x
Loan Facilities amended:
- Lower interest expense in Q3 (€4.4m) due to margin step down and repricing
- 0% US\$ Libor floor (previously 1%)
- RCF increased from €35m to €150m (€55m drawn) and US\$ term loan partially repaid (now \$340m)
Sustainability Commitment Reflected In Sector Leading ESG Ratings Connectivity and digitalization solutions for a more sustainable world
Carbon Neutral Operations since 2018 by GHG scope 1 & 2 emissions offset
Handprint Net Positive Assessment under way Quantifying the positive contribution of TeamViewer solutions to global emission reduction targets
UN Global Compact Signatory
Commitment to all UN SDGs with focus on 8 specific goals related to TeamViewer operations and solutions
Please note the disclaimer on page 28 For further information please visit: https://ir.teamviewer.com/websites/teamviewer/English/4700/sustainability-and-corporate-social-responsibility.html
Excluding Ubimax Raising FY 2020 Billings Guidance
Appendix
Q3 2020 Reconciliation From Management Key Metrics To IFRS
| €m | Management View Adjusted P&L |
Deferred Revenue |
D&A | Other non-IFRS Adjustments |
Accounting View IFRS P&L |
|---|---|---|---|---|---|
| Billings / Revenue | 106.4 | 10.7 | 117.2 | ||
| Cost Of Sales | (9.4) / (8 Billings) of 8% |
(6.8) | (0.2) | (16.4) / (14 Revenue) of 0% |
|
| Gross Profit Contribution | 97.1 / (91 of Billings) 2% |
100.8 / (85 of Revenue) 9% |
|||
| Sales | (14.0) / (13 of Billings) 2% |
(1.3) | (3.9) | (19.1) / (16 of Revenue) 3% |
|
| Marketing | (7.6) / (7 Billings) of 1% |
(0.4) | (1.5) | (9.5) / (8 Revenue) of 1% |
|
| R&D | (8.9) / (8 3)% of Billings) |
(1.3) | (1.9) | (12.1) / (10 of Revenue) 3% |
|
| G&A | (6.5) / (6 Billings) of 1% |
(0.5) | (8.7) | (15.7) / (13 Revenue) of 4% |
|
| Other1 | (2.0) / (1 Billings) of 8% |
- | 1.3 | (0.7) / (0 Revenue) of 6% |
|
| Adj. EBITDA | 58.2 / (54 of Billings) 7% |
||||
| D&A (ordinary only)2 | (4.1)2 | ||||
| Adj. EBIT / Operating profit (EBIT) | 54.1 / (50 of Billings) 8% |
10.7 | (6.2)3 | (14.9) | 43.8 / (37 of Revenue) 3% |
| D&A (total) | 10.3 | ||||
| EBITDA | 54.1 / (46 Revenue) of 1% |
1) incl. other income/expenses and bad debt expenses of €2.2m
2) D&A excl. amortization intangible assets from PPA
3) Amortization intangible assets from PPA
9M 2020 Reconciliation From Management Key Metrics To IFRS
| €m | Management View Adjusted P&L |
Deferred Revenue |
D&A | Other non-IFRS Adjustments |
Accounting View IFRS P&L |
|---|---|---|---|---|---|
| Billings / Revenue | 332.1 | 2.5 | 334.6 | ||
| Cost Of Sales | (26.3) / (7 of Billings) 9% |
(19.9) | (0.4) | (46.6) / (13 of Revenue) 9% |
|
| Gross Profit Contribution | 305.8 / (92 Billings) of 1% |
288.0 / (86 Revenue) of 1% |
|||
| Sales | (41.5) / (12 Billings) of 5% |
(3.6) | (7.5) | (52.6) / (15 Revenue) of 7% |
|
| Marketing | (21.8) / (6 of Billings) 6% |
(1.0) | (4.4) | (27.2) / (8 of Revenue) 1% |
|
| R&D | (24.2) / (7 3)% Billings) of |
(3.7) | (3.4) | (31.2) / (9 Revenue) of 3% |
|
| G&A | (19.0) / (5 of Billings) 7% |
(1.5) | (21.9) | (42.3) / (12 of Revenue) 7% |
|
| Other1 | (10.1) / (3 Billings) of 0% |
1.1 | (9.0) / (2 Revenue) of 7% |
||
| Adj. EBITDA | 189.3 / (57 Billings) of 0% |
||||
| D&A (ordinary only)2 | (11.6)2 | ||||
| Adj. EBIT / Operating profit (EBIT) | 177.7 / (53 Billings) of 5% |
2.5 | (18.0) 3 |
(36.5) | 125.7 / (37 Revenue) of 6% |
| D&A (total) | 29.6 | ||||
| EBITDA | 155.3/ (46 of Revenue) 4% |
1) incl. other income/expenses and bad debt expenses of €10.8m
2) D&A excl. amortization intangible assets from PPA
3) Amortization intangible assets from PPA
Non-IFRS Adjustments in EBITDA
Deferred Revenue Adjustments (€m) Other non-IFRS Adjustments (€m)
| Q3 20 | Q3 19 | 9M 20 | 9M 19 | |
|---|---|---|---|---|
| Billings | 106.5 | 82.7 | 332.1 | 224.3 |
| Perpetual Def. Revenue Release / (Addition) |
9.2 | 31.3 | 39.7 | 95.8 |
| Subscription Def. Revenue Release / (Addition) |
2.5 | (11.6) | (34.7) | (35.4) |
| Unallocated Def. Revenue Release / (Addition) |
(1.1) | (0.3) | (2.5) | (1.4) |
| Revenue | 117.2 | 102.0 | 334.6 | 283.3 |
- Perpetual deferred revenue now largely released with €9.2m remaining on balance sheet (see next page)
- Unallocated deferred revenue mainly consists of undue billings not recognized as receivables under IFRS 15
| Q3 20 | Q3 19 | 9M 20 | 9M 19 | |
|---|---|---|---|---|
| Total IFRS 2 Charges | (13.8) | (26.2) | (34.2) | (27.1) |
| TeamViewer LTIP | (0.6) | - | (1.0) | - |
| Ubimax Share Consideration | (3.3) | - | (3.3) | - |
| Share-based Compensation by TLO | (9.9) | (26.2) | (29.9) | (27.1) |
| Other Material Items | (2.4) | (11.9) | (3.4) | (16.0) |
| Financing, M&A, transaction-related | (0.9) | (0.5) | (1.1) | (0.6) |
| IPO related | - | (9.9) | 0.0 | (10.0) |
| Other | (1.5) | (1.6) | (2.3) | (5.4) |
| USD Hedge Valuation Gain/Loss | 1.3 | - | 1.1 | - |
| Total | (14.9) | (38.1) | (36.5) | (43.1) |
• TeamViewer cash-settled LTIP includes executive and key employee grants
- Ubimax share consideration recognized under IFRS 2 due to vesting condition with respect to continued employment of management
- Share-based compensation by TigerLux One (TLO) are fully funded by the selling shareholder in the IPO
Deferred Revenue Development
| Q3 20 | Q3 19 | 9M 20 | 9M 19 | |
|---|---|---|---|---|
| Perpetual Deferred Revenue (BoP) | 18.3 | 108.8 | 48.9 | 173.4 |
| (–) Release | 9.1 | 31.5 | 39.7 | 96.9 |
| (+) Addition | (0.0) | (0.1) | 0.0 | 1.1 |
| Perpetual Deferred Revenue (EoP) | 9.2 | 77.6 | 9.2 | 77.6 |
| Subscription Deferred Revenue (BoP) | 201.3 | 131.1 | 164.0 | 107.3 |
| (–) Release | 109.3 | 69.1 | 297.5 | 187.1 |
| (+) Addition | 106.6 | 80.6 | 332.2 | 222.5 |
| Subscription Deferred Revenue (EoP) | 198.6 | 142.7 | 198.6 | 142.7 |
| Total Deferred Revenue (BoP) | 219.6 | 239.9 | 212.8 | 280.6 |
| (–) Release | 118.4 | 100.2 | 337.3 | 283.9 |
| (+) Addition | 106.6 | 80.5 | 332.3 | 223.6 |
| Total Deferred Revenue (EoP) | 207.8 | 220.3 | 207.8 | 220.3 |
Profit & Loss Statement (unaudited)
| in EUR thousands | Q3 2020 | Q3 2019 | ∆ % | 9M 2020 | 9M 2019 | ∆ % |
|---|---|---|---|---|---|---|
| Revenue | 117,197 | 102,021 | 15% | 334,644 | 283,257 | 18% |
| Cost of sales | (16,352) | (12,646) | 29% | (46,637) | (36,418) | 28% |
| Gross profit | 100,845 | 89,374 | 13% | 288,006 | 246,839 | 17% |
| Other income | 1,504 | 7,843 | -81% | 2,025 | 15,856 | -87% |
| Research and development | (12,067) | (10,289) | 17% | (31,188) | (26,798) | 16% |
| Sales | (19,145) | (14,148) | 35% | (52,612) | (34,682) | 52% |
| Marketing | (9,484) | (6,186) | 53% | (27,218) | (17,344) | 57% |
| General and administrative | (15,735) | (43,515) | -64% | (42,335) | (63,822) | -34% |
| Other expenses | 62 | (431) | -114% | (230) | (478) | -52% |
| Bad debt expenses | (2,228) | (4,572) | -51% | (10,751) | (11,250) | -4% |
| Operating profit | 43,752 | 18,078 | 142% | 125,699 | 108,320 | 16% |
| Unrealised foreign exchange gains/(losses) |
12,372 | 3,336 | 271% | 15,196 | (1,347) | -1228% |
| Realised foreign exchange gains/(losses) |
382 | (21,344) | -102% | (1,342) | (20,078) | -93% |
| Finance income | 2,752 | 16,543 | -83% | 2,902 | 38,824 | -93% |
| Finance cost | (4,820) | (37,295) | -87% | (18,326) | (76,649) | -76% |
| Profit before taxation | 54,437 | (20,682) | -363% | 124,130 | 49,070 | 153% |
| Tax income/(expenses) | (22,812) | 34,294 | -167% | (50,042) | 10,265 | -588% |
| Profit/(loss) for the period | 31,625 | 13,613 | 132% | 74,088 | 59,335 | 25% |
| Other comprehensive income for the period | ||||||
| Items that may be reclassified to profit or loss in subsequent periods | (634) | 530 | -220% | (729) | 542 | -235% |
| Hedge reserve, gross | (14) | 6 | -319% | (76) | 8 | -1090% |
| Exchange differences on translation of foreign operations | (620) | 524 | -218% | (653) | 534 | -222% |
| Total comprehensive income for the period | 30,991 | 14,143 | 119% | 73,359 | 59,877 | 23% |
Balance Sheet (unaudited)
| in EUR thousands | 30 September 2020 | 31 December 2019 |
|---|---|---|
| Non-current assets |
||
| Goodwill | 647,117 | 590,445 |
| Intangible assets | 261,889 | 235,831 |
| Property, plant and equipment | 36,353 | 26,480 |
| Financial assets | 5,258 | 4,424 |
| Other assets | 864 | 1,740 |
| Deferred tax assets | 0 | 6,266 |
| Total non -current assets |
951,481 | 865,187 |
| Current assets |
||
| Inventories | 539 | 0 |
| Trade receivables | 16,068 | 11,756 |
| Other assets | 10,245 | 5,856 |
| Tax assets | 0 | 4,972 |
| Financial assets | 1,950 | 0 |
| Cash and cash equivalents | 52,969 | 71,153 |
| Total current assets | 81,772 | 93,737 |
| Total assets | 1,033,253 | 958,924 |
Balance Sheet (cont'd) (unaudited)
| in EUR thousands | 30 September 2020 | 31 December 2019 |
|---|---|---|
| Equity | ||
| Issued capital | 200,000 | 200,000 |
| Capital reserve | 353,854 | 320,661 |
| (Accumulated losses)/retained earnings | (355,793) | (429,881) |
| Hedge reserve | (76) | 0 |
| Foreign currency translation reserve | 428 | 1,081 |
| Total equity attributable to owners of the parent | 198,413 | 91,861 |
| liabilities Non-current |
||
| Provisions | 289 | 235 |
| Financial liabilities | 472,732 | 582,538 |
| Deferred revenue | 568 | 2,572 |
| Deferred and other liabilities | 975 | 0 |
| Deferred tax liabilities | 21,449 | 308 |
| Total non -current liabilities |
496,014 | 585,652 |
| liabilities Current |
||
| Provisions | 2,118 | 3,284 |
| Financial liabilities | 82,606 | 34,260 |
| Trade payables | 8,312 | 9,069 |
| Deferred revenue | 207,255 | 210,250 |
| Deferred and other liabilities | 35,158 | 17,793 |
| Other financial liabilities | 62 | 6,642 |
| Tax liabilities | 3,315 | 114 |
| Total current liabilities | 338,826 | 281,411 |
| Total liabilities | 834,840 | 867,063 |
| Total equity and liabilities | 1,033,253 | 958,924 |
Cash Flow Statement (unaudited)
| in EUR thousands | Q3 2020 | Q3 2019 | 9M 2020 | 9M 2019 |
|---|---|---|---|---|
| Cash flows from operating activities |
||||
| Profit before taxation | 54,437 | (20,682) | 124,130 | 49,070 |
| Depreciation, amortisation and impairment of non-current assets |
10,319 | 9,190 | 29,641 | 27,096 |
| (Gain)/loss from the sale of property, plant and equipment | 4 | (18) | 7 | (18) |
| Increase/(decrease) in provisions | 841 | 806 | (137) | 669 |
| Non-operational foreign exchange (gains)/ losses |
(14,041) | 17,423 | (17,342) | 20,320 |
| Expenses for share-based compensation | 12,782 | 26,188 | 33,193 | 27,088 |
| Net financial result | 2,068 | 20,751 | 15,424 | 37,825 |
| Change in deferred revenue | (11,915) | (19,721) | (5,116) | (61,250) |
| Changes in other net working capital and other | 2,784 | 2,040 | 5,170 | (1,850) |
| Income tax paid | (7,040) | (4,983) | (24,707) | (15,245) |
| Interest paid / received other than from financing activities | 128 | 0 | 94 | (18) |
| Net cash from operating activities | 50,366 | 30,994 | 160,357 | 83,688 |
| Cash flows from investing activities |
||||
| Capital expenditure for property, plant and equipment and intangible assets | (7,686) | (218) | (22,781) | (8,144) |
| Proceeds from the sale of property, plant and equipment | 23 | 18 | 23 | 18 |
| Payments for the acquisition of non-current financial assets | 0 | 0 | (51) | 0 |
| Interest received | (151) | 131 | 0 | 382 |
| Acquisition of subsidiaries | (84,053) | 0 | (84,053) | 0 |
| Net cash used in investing activities | (91,867) | (69) | (106,862) | (7,744) |
Cash Flow Statement (cont'd) (unaudited)
| in EUR thousands | Q3 2020 | Q3 2019 | 9M 2020 | 9M 2019 |
|---|---|---|---|---|
| Cash flows from financing activities |
||||
| Repayments of borrowings | (38,987) | (126,651) | (38,987) | (179,113) |
| Proceeds from bank borrowings | 0 | 74,017 | 0 | 74,017 |
| Payments for the capital element of lease liabilities |
(1,602) | (1,470) | (3,358) | (3,839) |
| Interest paid for borrowings and lease liabilities |
(11,201) | (225) | (24,837) | (26,505) |
| Proceeds/(payments) from the settlement of derivatives | 0 | (34) | 0 | (98) |
| Proceeds/(payments) in equity | 0 | 25 | 0 | 25 |
| Net cash used in financing activities | (51,790) | (54,337) | (67,182) | (135,512) |
| Net change in cash and cash equivalents | (93,291) | (23,412) | (13,687) | (59,568) |
| Net foreign exchange rate difference | (4,083) | 1,258 | (4,614) | 1,646 |
| Net change from cash risk provisioning | 588 | 69 | 117 | 914 |
| Internal combinations and transfers | 0 | (0) | 0 | 3,768 |
| Cash and cash equivalents at beginning of period | 149,755 | 48,783 | 71,153 | 79,939 |
| Cash and cash equivalents at end of period | 52,969 | 26,698 | 52,969 | 26,698 |
Disclaimer
The use by TeamViewer AG of any MSCI ESG Research LLC or its affiliates ("MSCI") data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of TeamViewer AG by MSCI. MSCI Services and data are the property of MSCI or its information providers, and are provided 'as-is' and without warranty. MSCI names and logos are trademarks or service marks of MSCI.
Copyright ©2020 Sustainalytics. All rights reserved. This [publication/ article/ section] contains information developed by Sustainalytics (www.sustainalytics.com). Such information and data are proprietary of Sustainalytics and/or its third party suppliers (Third Party Data) and are provided for informational purposes only. They do not constitute an endorsement of any product or project, nor an investment advice and are not warranted to be complete, timely, accurate or suitable for a particular purpose. Their use is subject to conditions available at https://www.sustainalytics.com/legaldisclaimers.
Climate Neutrality: TeamViewer compensates its own operations based emissions since 2018 with official certificates provided by Plant-for-the-Planet.